For: | Thomassin L, Armengol-Debeir L, Charpentier C, Bridoux V, Koning E, Savoye G, Savoye-Collet C. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease. World J Gastroenterol 2017; 23(23): 4285-4292 [PMID: 28694669 DOI: 10.3748/wjg.v23.i23.4285] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i23/4285.htm |
Number | Citing Articles |
1 |
Mary-Louise C. Greer, Stuart A. Taylor. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the AJR Special Series on Imaging of Inflammation. American Journal of Roentgenology 2022; 218(5): 781 doi: 10.2214/AJR.21.26615
|
2 |
Giulio Aniello Santoro, Christian Raymond S. Magbojos, Giovanni Maconi, Iwona Sudoł-Szopińska. Pelvic Floor Disorders. 2021; : 1003 doi: 10.1007/978-3-030-40862-6_81
|
3 |
Viviane Lin, Seyma Gögenur, Frederik Pachler, Tina Fransgaard, Ismail Gögenur. Risk Prediction for Complications in Inflammatory Bowel Disease Surgery: External Validation of the American College of Surgeons’ National Surgical Quality Improvement Program Surgical Risk Calculator. Journal of Crohn's and Colitis 2023; 17(1): 73 doi: 10.1093/ecco-jcc/jjac114
|
4 |
Marion Chambaz, Mikael Verdalle-Cazes, Charlotte Desprez, Lucie Thomassin, Cloé Charpentier, Sébastien Grigioni, Laura Armengol-Debeir, Valérie Bridoux, Guillaume Savoye, Céline Savoye-Collet. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn’s disease. Digestive and Liver Disease 2019; 51(3): 358 doi: 10.1016/j.dld.2018.12.010
|
5 |
Nicolas Richard, Antonin Derinck, Valérie Bridoux, Cloé Charpentier, Céline Savoye Collet, Guillaume Savoye. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn’s disease?. Abdominal Radiology 2024; 49(8): 2913 doi: 10.1007/s00261-024-04238-3
|
6 |
Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02676-9
|
7 |
Xue-Liang Sun, Shi-Yi Chen, Shan-Shan Tao, Li-Chao Qiao, Hong-Jin Chen, Bo-Lin Yang. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World Journal of Gastroenterology 2020; 26(14): 1554-1563 doi: 10.3748/wjg.v26.i14.1554
|
8 |
David A. Schwartz, Laurent Peyrin-Biroulet, Karen Lasch, Shashi Adsul, Silvio Danese. Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn’s Disease: ENTERPRISE Study. Clinical Gastroenterology and Hepatology 2022; 20(5): 1059 doi: 10.1016/j.cgh.2021.09.028
|
9 |
Xiaohan Yan, Mingming Zhu, Qi Feng, Yunqi Yan, Jiangchen Peng, Xitao Xu, Antao Xu, Zhihua Ran. Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging. Gastroenterology Report 2019; 7(1): 50 doi: 10.1093/gastro/goy036
|
10 |
Pankaj Garg, Vipul D. Yagnik, Baljit Kaur, Geetha R. Menon, Sushil Dawka. Role of MRI to confirm healing in complex high cryptoglandular anal fistulas: long‐term follow‐up of 151 cases. Colorectal Disease 2021; 23(9): 2447 doi: 10.1111/codi.15695
|
11 |
Tanya Lee, Eric Yong, Nik S Ding. Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis. JGH Open 2020; 4(3): 340 doi: 10.1002/jgh3.12295
|
12 |
Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath. Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review. Journal of Crohn's and Colitis 2024; 18(6): 836 doi: 10.1093/ecco-jcc/jjad214
|
13 |
Firas Rinawi, Mary-Louise C. Greer, Thomas Walters, Peter C. Church, Amanda Ricciuto, Jacob C. Langer, Anne M Griffiths. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?. Journal of Pediatric Surgery 2022; 57(11): 569 doi: 10.1016/j.jpedsurg.2022.03.031
|
14 |
UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
|
15 |
Arshdeep Singh, Chandan Kakkar, Shreya Garg, Kirti Arora, Vandana Midha, Ramit Mahajan, Satpal Singh Virk, Narender Pal Jain, Dharmatma Singh, Kriti Sood, Ashish Tripathi, Dhruv Gupta, Ishita Gupta Kaushal, Ritu Dhawan Galhotra, Kavita Saggar, Ajit Sood. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn’s disease: A cohort study from northern India. Indian Journal of Gastroenterology 2023; 42(5): 668 doi: 10.1007/s12664-023-01399-9
|
16 |
Nicola S. Fearnhead. Inflammatory Bowel Disease Nursing Manual. 2019; : 173 doi: 10.1007/978-3-319-75022-4_20
|
17 |
Parul Tandon, Glara Gaeun Rhee, David Schwartz, Jeffrey D. McCurdy. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn’s Disease: A Systematic Review. Digestive Diseases and Sciences 2019; 64(11): 3066 doi: 10.1007/s10620-019-05635-1
|
18 |
Tanya Lee, Michael A Kamm, Sally Bell, Mark Lust, Steve Brown, Ola Niewiadomski, Chamara Basnayake, Emily Wright, Basil D'Souza, Rodney Woods, Shu Chen Wei, William Connell, Alexander Thompson, Eric Yong, Nik Sheng Ding. Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era. JGH Open 2021; 5(2): 235 doi: 10.1002/jgh3.12475
|
19 |
Laura Sirmai, Anne-Laure Pelletier, Nathalie Gault, Camille Zallot, Guillaume Bouguen, Dominique Bouchard, Pascale Roland Nicaise, Marine Peyneau, Sandrine Sironneau, Marcelo De Carvalho Bittencourt, Antoine Petitcollin, Pedro Fernandez, Xavier Roblin, Laurent Siproudhis, Laurent Abramowitz. Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study. World Journal of Gastroenterology 2022; 28(9): 961-972 doi: 10.3748/wjg.v28.i9.961
|
20 |
Bénédicte Caron, Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet. Endpoints for Perianal Crohn’s Disease Trials: Past, Present and Future. Journal of Crohn's and Colitis 2021; 15(8): 1387 doi: 10.1093/ecco-jcc/jjab026
|
21 |
Jeffrey D. McCurdy, Javeria Munir, Simon Parlow, Jacqueline Reid, Russell Yanofsky, Talal Alenezi, Joseph Meserve, Brenda Becker, Zubin Lahijanian, Anas Hussam Eddin, Ranjeeta Mallick, Tim Ramsay, Greg Rosenfeld, Ali Bessissow, Talat Bessissow, Vipul Jairath, Siddharth Singh, David H. Bruining, Blair Macdonald. Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study. Clinical Gastroenterology and Hepatology 2024; 22(5): 1058 doi: 10.1016/j.cgh.2023.12.006
|
22 |
Etienne Buscail, Guillaume Le Cosquer, Fabian Gross, Marine Lebrin, Laetitia Bugarel, Céline Deraison, Nathalie Vergnolle, Barbara Bournet, Cyrielle Gilletta, Louis Buscail. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and Perspectives. International Journal of Molecular Sciences 2021; 22(18): 9967 doi: 10.3390/ijms22189967
|
23 |
Fabian Juliao-Baños, Carlos Fernando Grillo A, Luis Fernando Pineda Ovalle, William Otero Regino. , María Teresa Galiano de Sánchez. , Rafael García Duperly. , María Teresa Vallejo O. , Marcela Torres Amaya. . Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta . Revista Colombiana de Gastroenterología 2020; 35(Supl. 2): 63 doi: 10.22516/25007440.637
|
24 |
Nadia Fathallah, Cosmin Cristea, Hélène Beaussier, Sonia Khirani, Vincent de Parades. Infliximab for Anoperineal Lesions in Crohn's Disease: Remission Appears to be Based on Rapid Combination Therapy at High Doses. Journal of Coloproctology 2022; 42(02): 126 doi: 10.1055/s-0041-1739549
|
25 |
Wan-Ting Cao, Rong Huang, Ke-Fang Jiang, Xue-Hui Qiao, Jing-Jing Wang, Yi-Hong Fan, Yi Xu. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(9): 886-907 doi: 10.3748/wjg.v27.i9.886
|
26 |
Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli. Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification. European Journal of Gastroenterology & Hepatology 2020; 32(2): 187 doi: 10.1097/MEG.0000000000001634
|
27 |
Torsten Kucharzik, Jeroen Tielbeek, Dan Carter, Stuart A Taylor, Damian Tolan, Rune Wilkens, Robert V Bryant, Christine Hoeffel, Isabelle De Kock, Christian Maaser, Giovanni Maconi, Kerri Novak, Søren R Rafaelsen, Martina Scharitzer, Antonino Spinelli, Jordi Rimola. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(4): 523 doi: 10.1093/ecco-jcc/jjab180
|
28 |
Konstantinos Papamichael, Adam S Cheifetz. Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy. World Journal of Gastroenterology 2017; 23(34): 6197-6200 doi: 10.3748/wjg.v23.i34.6197
|
29 |
Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu. Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View. Annals of Coloproctology 2021; 37(1): 5 doi: 10.3393/ac.2021.02.08
|